12.05.2011
Kievmedpreparat OJSC, which is the part of Arterium Corporation, has released the first series of the new drug Inspiron®, tablets, film-coated, 80 mg.
The drug Inspiron®, tablets intended for treatment of acute and chronic inflammation of upper respiratory tract and respiratory tract infection (otitis media, sinusitis, rhinitis, nasopharyngitis, tracheitis, rinotraheobronhit, bronchitis), chronic obstructive pulmonary disease (COPD) in the complex treatment of bronchial asthma, seasonal and perennial allergic rhinitis and other allergies of the respiratory system and in otolaryngology, respiratory manifestations of measles, influenza, and symptomatic treatment of pertussis.
The product contains the active ingredient - fenspiride hydrochloride, which has a high safety profile, high bioavailability and good tolerability (no side effects of corticosteroids and nonsteroidal anti-inflammatory drugs).
The main advantages of the drug Inspiron®, tablets are:
- Proven in clinical trials, bioequivalence to an original medicinal product;
- Ease of use for patients.
The drug was developed by the Research Centre of Kievmedpreparat OJSC.
The drug Inspiron ®, tablets must be administered strictly under prescription of a doctor.
This information hasreference purpose and is intended for use by professionals
Similar products
INSPIRON® (Tablets) (Tablets, covered with film coat)
INSPIRON (Syrup) (Syrup)
